Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02025907
What this trial is testing

Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 218
Early research (Phase 1)Study completedNCT07213895
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 14
Not applicableActive Not RecruitingNCT06907472
What this trial is testing

Diabetes Management for Primary Healthcare Centers.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University of Abuja 106
Testing effectiveness (Phase 2)Study completedNCT06199505
What this trial is testing

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 153
Early research (Phase 1)Study completedNCT07266766
What this trial is testing

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 40
Not applicableActive Not RecruitingNCT07172997
What this trial is testing

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Who this might be right for
MASLDT2DM (Type 2 Diabetes Mellitus)Non-alcoholic Fatty Liver Disease (NAFLD)+1 more
Royal College of Surgeons in Ireland - Medical University of Bahrain 163
Testing effectiveness (Phase 2)UnknownNCT04014023
What this trial is testing

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Daewoong Pharmaceutical Co. LTD. 196
Testing effectiveness (Phase 2)Study completedNCT01163721
What this trial is testing

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Gilead Sciences 80
Early research (Phase 1)Study completedNCT03033433
What this trial is testing

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Who this might be right for
Type2 Diabetes
VitNovo, Inc. 28
Not applicableLooking for participantsNCT07241221
What this trial is testing

Antenatal Myo-inositol Supplementation in Pre-existing Diabetes

Who this might be right for
Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
National University Hospital, Singapore 182
Early research (Phase 1)Study completedNCT07801326
What this trial is testing

Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese Participants

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd 162
Post-approval studies (Phase 4)Study completedNCT06855615
What this trial is testing

Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Hospital Sultanah Aminah Johor Bahru 44
Not applicableLooking for participantsNCT06003634
What this trial is testing

OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Medical Branch, Galveston 25
Not applicableStudy completedNCT06953609
What this trial is testing

Prediabetes and Type 2 Diabetes in Aging

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cognitive FunctionDual Task+2 more
Uşak University 94
Testing effectiveness (Phase 2)Study completedNCT02561338
What this trial is testing

A Multi-center 12-week Study of HMS5552 in T2DM

Who this might be right for
Diabetes Mellitus, Type 2
Hua Medicine Limited 258
Not applicableStudy completedNCT05561855
What this trial is testing

T2DM Intensity Lifestyle Intervention

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
Ningbo No. 1 Hospital 120
Early research (Phase 1)Study completedNCT06948747
What this trial is testing

Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 49
Testing effectiveness (Phase 2)Study completedNCT07055516
What this trial is testing

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity and Type 2 Diabetes
Rezera (formerly NodThera Limited) 176
Not applicableWithdrawnNCT00534547
What this trial is testing

Duodenal Exclusion for the Treatment of Type 2 Diabetes

Who this might be right for
Diabetes
Medtronic - MITG
Testing effectiveness (Phase 2)Study completedNCT05514548
What this trial is testing

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Inversago Pharma Inc. 265
Next Page